Maximus, Inc. reports developments tied to its role as a provider of tech-enabled government services for public programs. The company supports government agencies with business process management, technology solutions, health insurance eligibility and enrollment programs, clinical services, assessments, appeals and independent medical reviews across U.S. Federal Services, U.S. Services and international operations.
Recurring news includes fiscal results, guidance updates, sales-pipeline commentary, segment trends, clinical program demand and productivity initiatives. Company updates also cover AI-enabled tools such as Accuracy Assistant for state SNAP programs, quarterly cash dividends, common-stock repurchase authorizations and governance changes involving senior legal and corporate-secretary roles.
Spire Global (NYSE: SPIR) appointed John Martinez to its board of directors, effective March 9, 2026. Martinez is chief legal officer at Parsons and previously served as chief legal officer at Maximus, bringing more than two decades of government, defense, and intelligence sector experience to Spire.
The appointment underscores Spire's focus on expanding sovereign-ready space intelligence for U.S. and allied partners.
Maximus (NYSE: MMS) reported Q1 FY2026 results for quarter ended December 31, 2025: revenue $1.35B, diluted EPS $1.70, and adjusted diluted EPS $1.85. The company narrowed revenue guidance to $5.2B–$5.35B, raised adjusted diluted EPS guidance to $8.05–$8.35, and increased adjusted EBITDA margin to ~14%. A quarterly cash dividend of $0.33 is payable March 2, 2026.
Cash used in operations was $244M and free cash flow was an outflow of $251M; sales pipeline totaled $59.1B.
Maximus (NYSE: MMS) launched Accuracy Assistant, an AI-enabled suite for state SNAP programs that uses predictive analytics, intelligent automation, and NLP to identify data inconsistencies and flag high-risk cases in real time before benefits are issued. The tool offers eligibility inconsistency detection, side-by-side staff support with policy guidance, auto-generated interaction summaries, and interactive dashboards for monitoring. The launch is timed ahead of federal SNAP changes requiring states to fund a portion of benefits starting October 2027 when state payment error rates exceed 6%. Maximus positions the product as a preventative quality-assurance solution to reduce error rates and strengthen program integrity.
Maximus (NYSE: MMS) will release fiscal 2026 first quarter results for the three months ended December 31, 2025 on Thursday, February 5, 2026 at 6:30 a.m. ET. The company will host a public conference call the same day at 9:00 a.m. ET, accessible by webcast and by phone at 877.407.8289 (Domestic) or +1.201.689.8341 (International). A recording of the webcast will be available afterward at investor.maximus.com.
Maximus (NYSE: MMS) announced a quarterly cash dividend of $0.33 per share, a 10% increase from the prior quarterly dividend of $0.30.
The Board approved the dividend payable on March 2, 2026 to shareholders of record on February 13, 2026. Management said the increase reflects recent earnings growth and the company’s disciplined capital deployment strategy.
Maximus (NYSE: MMS) reported fiscal 2025 results with $5.43B revenue, up 2.4% year-over-year and 3.9% organic growth driven by U.S. Federal clinical programs. Fiscal operating margin expanded to 9.7% and adjusted EBITDA margin to 12.9%. Adjusted diluted EPS was $7.36 and free cash flow totaled $366M. The company repurchased ~5.8M shares for $456.6M and ended the year with net leverage of 1.5x. Management declared a quarterly dividend of $0.30 per share payable Dec 1, 2025. For fiscal 2026, Maximus provided guidance: revenue of $5.225B–$5.425B, adjusted EBITDA margin ~13.7%, adjusted diluted EPS $7.95–$8.25, and free cash flow $450M–$500M.
Maximus (NYSE: MMS) was awarded a Joint Cyber Command & Control Readiness (JCC2-R) contract by the U.S. Air Force Life Cycle Management Center with a potential value of $86 million to support engineering analysis, software modification, maintenance, enhancements, and maturation of existing architecture and infrastructure.
The award is a second task order from the Air Force and carries a period of performance of a base year plus four one-year option periods and an optional six-month extension, expanding Maximus' technology footprint in the defense sector.
Maximus (NYSE: MMS) was awarded a new $31 million contract by the Massachusetts Health Connector to provide enrollment and premium billing services under a four-year base term.
The scope includes credit/debit processing, enrollment data reconciliation with carriers, federal reporting notices, and a redesigned digital member portal to serve > 370,000 marketplace members. Maximus said its technology will interface with Health Connector systems, insurers, and vendors to modernize premium payments and member experience.
Maximus (NYSE: MMS) will release fiscal 2025 fourth quarter and year-end results for the periods ended September 30, 2025 at 6:30 a.m. ET on Thursday, November 20, 2025. The company will host a public conference call and webcast the same day at 9:00 a.m. ET.
Investors can join by phone at 877.407.8289 (Domestic) or +1.201.689.8341 (International), or stream the webcast. A recording will be posted at investor.maximus.com for later access.
Maximus (NYSE: MMS) announced on October 6, 2025 that its Board approved a quarterly cash dividend of $0.30 per share. According to the press release, the dividend is payable on December 1, 2025 to shareholders of record on November 14, 2025. The PR states these dates and the dividend amount only.